Verrica Pharmaceuticals Inc (NAS:VRCA)
$ 0.6843 0.0356 (5.49%) Market Cap: 61.97 Mil Enterprise Value: 82.90 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Verrica Pharmaceuticals Inc VIRTUAL PANEL: The Pursuit of Molluscum - Beetlejuice and Nobel Prizes Transcript

Sep 22, 2020 / NTS GMT
Release Date Price: $8.47 (-2.98%)
John Vandermosten;s Small Cap Research;Analyst
Zack

'-

Good day, everybody. My name is John Vandermosten. And today we'll be presenting a virtual panel called The Pursuit of Molluscum -- Beetlejuice and Nobel. And we're going to find out what those two terms mean in just a few minutes.

Today, we are going to introduce the CEOs of two of the leading companies developing a treatment for molluscum contagiosum. Molluscum is a pox virus that causes a skin condition with white bumps that can be itchy, painful, unsightly, and it's also highly contagious. There are estimated to be about 6 million individuals in the US and above 120 million around the globe that are afflicted with the virus.

Molluscum is most common in children and the infection is associated with daycare centers, contact sports, and other situations where children are in close contact with each other. And probably most parents who have children, who are wrestling or swimming, or another kind of sport like this are quite familiar with the disease.

Novan is advancing its candidate called

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot